Alumis Inc (ALMS)

Apr 21, 2025

Revised merger terms boost ACELYRIN stake in Alumis deal By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Alumis And Acelyrin Announce Amended Merger Agreement - marketscreener.com

Apr 21, 2025

Apr 21, 2025

Alumis, ACELYRIN amend proposed merger pact - Seeking Alpha

Apr 21, 2025

Apr 21, 2025

Alumis Raises Share Consideration for Acelyrin Acquisition - marketscreener.com

Apr 21, 2025

Apr 21, 2025

ACELYRIN, INC. Amends Merger Agreement with Alumis - TipRanks

Apr 21, 2025

Apr 21, 2025

ACELYRIN and Alumis Announce Revised Merger Agreement Enhancing Stockholder Ownership and Value - Nasdaq

Apr 21, 2025

Apr 21, 2025

Alumis and ACELYRIN Announce Amended Merger Agreement - The Manila Times

Apr 21, 2025

Apr 21, 2025

Alumis Secures Major Immunology Merger: $737M Cash Runway Stretches to 2027, 62% Shareholders Back Deal - Stock Titan

Apr 21, 2025

Apr 16, 2025

ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc.SLRN - MarketScreener

Apr 16, 2025

Apr 14, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Apr 14, 2025

Apr 14, 2025

Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga

Apr 14, 2025

Apr 10, 2025

3 Biopharmaceutical Stocks Bucking the Sell-Off - MarketBeat

Apr 10, 2025

Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 08, 2025

Apr 07, 2025

Alumis: Biotech's Stock Gains >100% In A MonthBut Risk Of Failure Is High (NASDAQ:ALMS) - Seeking Alpha

Apr 07, 2025

Apr 07, 2025

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Apr 07, 2025

Apr 05, 2025

Alumis Reaches US$465m Market Cap Benefiting Insider Stock Buying - simplywall.st

Apr 05, 2025

Apr 05, 2025

Insider Buying: Alumis Independent Director Bought US$130k Of Shares - Yahoo

Apr 05, 2025

Apr 05, 2025

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger - The Manila Times

Apr 05, 2025

Apr 04, 2025

Alumis and ACELYRIN announce definitive merger plan By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Alumis and ACELYRIN announce definitive merger plan - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

Major Biopharma Merger: Alumis and ACELYRIN Unite with $737M War Chest for Immune Disease Breakthroughs - Stock Titan

Apr 04, 2025

Apr 04, 2025

Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday - Benzinga

Apr 04, 2025

Apr 04, 2025

Alumis Inc. CEO Martin Babler buys $100,732 in company stock By Investing.com - Investing.com Australia

Apr 04, 2025

Apr 04, 2025

Alumis Inc. director Alan Colowick buys $129,544 in stock By Investing.com - Investing.com Australia

Apr 04, 2025

Apr 03, 2025

Top Executives Make Bold Moves with Alumis Inc. Stock Purchases! - TipRanks

Apr 03, 2025

Apr 03, 2025

Alumis Inc. CEO Martin Babler buys $100,732 in company stock - Investing.com

Apr 03, 2025

Apr 03, 2025

Alumis Inc. director Alan Colowick buys $129,544 in stock - Investing.com

Apr 03, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 02, 2025

Apr 01, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, BECN, SLRN, ALMS on Behalf of Shareholders - The Malaysian Reserve

Apr 01, 2025

Apr 01, 2025

Progress Software Posts Upbeat Results, Joins Microvast, PVH And Other Big Stocks Moving Higher On Tuesday - Benzinga

Apr 01, 2025

Apr 01, 2025

Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025

Mar 31, 2025

Alumis Inc. (NASDAQ:ALMS) Stock Holdings Increased by Charles Schwab Investment Management Inc. - Defense World

Mar 31, 2025

Mar 30, 2025

Q2 Earnings Forecast for Alumis Issued By Leerink Partnrs - MarketBeat

Mar 30, 2025

Mar 30, 2025

The week in pharma: action, reaction and insight – week to March 28 - The Pharma Letter

Mar 30, 2025

Mar 28, 2025

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars - insights.citeline.com

Mar 28, 2025

Mar 28, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDW, BHLB, MHLD, SLRN on Behalf of Shareholders - The Malaysian Reserve

Mar 28, 2025

Mar 28, 2025

Last-minute suitor nearly upends Alumis, Acelyrin merger - The Business Journals

Mar 28, 2025

Mar 27, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – SLRN - Bluefield Daily Telegraph

Mar 27, 2025

Mar 27, 2025

Alumis and Kaken Pharma announce collaboration worth $140 M for dermatology treatment in Japan - BioSpectrum Asia

Mar 27, 2025

Mar 27, 2025

Alumis Inc. Reports 2024 Results and Strategic Merger - TipRanks

Mar 27, 2025

Mar 26, 2025

Strategic Partnerships and Financial Projections Bolster Buy Rating for Alumis Inc. - TipRanks

Mar 26, 2025

Mar 26, 2025

Alumis stock holds $15 target, Buy rating at H.C. Wainwright By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Alumis stock holds $15 target, Buy rating at H.C. Wainwright - Investing.com

Mar 26, 2025

Mar 26, 2025

Q1 Earnings Forecast for Alumis Issued By Leerink Partnrs - Defense World

Mar 26, 2025

Mar 26, 2025

Alumis sees uptick as Kaken locks Japan rights for dermatology asset - FirstWord Pharma

Mar 26, 2025

Mar 25, 2025

Alumis and Kaken Pharmaceutical Announce Collaboration and - GlobeNewswire

Mar 25, 2025

Mar 25, 2025

Alumis rises on licensing deal with Japan’s Kaken - MSN

Mar 25, 2025

Mar 25, 2025

Acelyrin Sees Stock Price Rise Amid Rights Plan - Los Angeles Business Journal

Mar 25, 2025

Mar 25, 2025

What's Going On With Alumis Shares Tuesday? - Benzinga

Mar 25, 2025